kabutan

Immuno-Biological Laboratories Co., Ltd.(4570) Summary

4570
TSE Growth
Immuno-Biological Laboratories Co., Ltd.
1,526
JPY
+14
(+0.93%)
Jan 29, 1:38 pm JST
9.97
USD
Jan 28, 11:38 pm EST
Result
PTS
outside of trading hours
1,523
Jan 29, 1:30 pm JST
Summary Chart Historical News Financial Result
PER
53.6
PBR
8.59
Yield
0.39%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,527 JPY 9.97 USD
Previous Close Jan 28
1,512 JPY 9.90 USD
High Jan 29, 9:03 am
1,560 JPY 10.18 USD
Low Jan 29, 9:47 am
1,486 JPY 9.71 USD
Volume
312,300
Trading Value
0.48B JPY 3.10M USD
VWAP
1520.46 JPY 9.94 USD
Minimum Trading Value
152,600 JPY 997 USD
Market Cap
0.01T JPY 0.09B USD
Number of Trades
1,273
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
2,900
1-Year High Dec 30, 2025
93,496
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 1,367,600
Jan 16, 2026 0 1,412,700
Jan 9, 2026 100 1,354,200 13542.00
Dec 26, 2025 4,800 1,168,000 243.33
Dec 19, 2025 4,500 1,131,200 251.38
Company Profile
Immuno-Biological Laboratories Co., Ltd. manufactures and sells research reagents and offers contract services. The silkworm development business has been suspended. The company has entered the cosmetics business.
Sector
Pharmaceuticals
Immuno-Biological Laboratories Co., Ltd. primarily manufactures and sells antibody-based research reagents, in vitro diagnostic pharmaceuticals, and raw materials for in vitro diagnostic pharmaceuticals. The company also develops pharmaceutical seeds utilizing antibody production technology and provides the lipoprotein profiling analysis service "LipoSEARCH". Additionally, the company offers contract services for mass production of proteins and antibodies using genetically modified silkworm technology. Furthermore, in the cosmetics sector, Immuno-Biological Laboratories Co., Ltd. focuses on developing and selling products containing silkworm-derived "NeoSilk-Human Collagen I".